Amgen Inc Stock Net Income
| AMG Stock | 310.20 22.80 7.93% |
As of the 5th of February, Amgen shows the risk adjusted performance of 0.1259, and Mean Deviation of 1.53. Amgen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Amgen Total Revenue |
|
Market Capitalization 105.2 B | Enterprise Value Revenue 6.1984 |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 3.7 B | 5 B | |
| Net Income | 3.7 B | 5 B |
Amgen | Net Income |
The evolution of Net Income for Amgen Inc provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Amgen compares to historical norms and industry peers.
Latest Amgen's Net Income Growth Pattern
Below is the plot of the Net Income of Amgen Inc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Amgen Inc financial statement analysis. It represents the amount of money remaining after all of Amgen Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Amgen's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amgen's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 4.09 B | 10 Years Trend |
|
Net Income |
| Timeline |
Amgen Net Income Regression Statistics
| Arithmetic Mean | 6,557,884,967 | |
| Geometric Mean | 6,209,729,264 | |
| Coefficient Of Variation | 27.80 | |
| Mean Deviation | 1,427,560,630 | |
| Median | 7,722,000,000 | |
| Standard Deviation | 1,823,058,194 | |
| Sample Variance | 3323541.2T | |
| Range | 6.4B | |
| R-Value | (0.56) | |
| Mean Square Error | 2447606.1T | |
| R-Squared | 0.31 | |
| Significance | 0.02 | |
| Slope | (200,871,678) | |
| Total Sum of Squares | 53176658.9T |
Amgen Net Income History
Amgen 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Amgen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Amgen.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in Amgen on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Amgen Inc or generate 0.0% return on investment in Amgen over 90 days. Amgen is related to or competes with Host Hotels, MIRAMAR HOTEL, FUYO GENERAL, Sekisui Chemical, UNITED RENTALS, Lendlease, and PTT Global. Amgen is entity of Germany. It is traded as Stock on STU exchange. More
Amgen Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Amgen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Amgen Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.77 | |||
| Information Ratio | 0.1327 | |||
| Maximum Drawdown | 12.15 | |||
| Value At Risk | (2.96) | |||
| Potential Upside | 3.98 |
Amgen Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amgen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Amgen's standard deviation. In reality, there are many statistical measures that can use Amgen historical prices to predict the future Amgen's volatility.| Risk Adjusted Performance | 0.1259 | |||
| Jensen Alpha | 0.3458 | |||
| Total Risk Alpha | 0.1832 | |||
| Sortino Ratio | 0.1642 | |||
| Treynor Ratio | 182.06 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Amgen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Amgen February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1259 | |||
| Market Risk Adjusted Performance | 182.07 | |||
| Mean Deviation | 1.53 | |||
| Semi Deviation | 1.44 | |||
| Downside Deviation | 1.77 | |||
| Coefficient Of Variation | 617.02 | |||
| Standard Deviation | 2.2 | |||
| Variance | 4.82 | |||
| Information Ratio | 0.1327 | |||
| Jensen Alpha | 0.3458 | |||
| Total Risk Alpha | 0.1832 | |||
| Sortino Ratio | 0.1642 | |||
| Treynor Ratio | 182.06 | |||
| Maximum Drawdown | 12.15 | |||
| Value At Risk | (2.96) | |||
| Potential Upside | 3.98 | |||
| Downside Variance | 3.15 | |||
| Semi Variance | 2.07 | |||
| Expected Short fall | (1.69) | |||
| Skewness | 1.18 | |||
| Kurtosis | 3.17 |
Amgen Inc Backtested Returns
Amgen appears to be very steady, given 3 months investment horizon. Amgen Inc secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Amgen Inc, which you can use to evaluate the volatility of the firm. Please makes use of Amgen's risk adjusted performance of 0.1259, and Mean Deviation of 1.53 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Amgen holds a performance score of 9. The firm shows a Beta (market volatility) of 0.0019, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Amgen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Amgen is expected to be smaller as well. Please check Amgen's maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to make a quick decision on whether Amgen's price patterns will revert.
Auto-correlation | -0.2 |
Insignificant reverse predictability
Amgen Inc has insignificant reverse predictability. Overlapping area represents the amount of predictability between Amgen time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Amgen Inc price movement. The serial correlation of -0.2 indicates that over 20.0% of current Amgen price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.2 | |
| Spearman Rank Test | -0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 53.1 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Amgen Net Interest Income
Net Interest Income |
|
Based on the recorded statements, Amgen Inc reported net income of 4.09 B. This is much higher than that of the Metals & Mining sector and significantly higher than that of the Materials industry. The net income for all Germany stocks is notably lower than that of the firm.
Amgen Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amgen's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amgen could also be used in its relative valuation, which is a method of valuing Amgen by comparing valuation metrics of similar companies.Amgen is currently under evaluation in net income category among its peers.
Amgen ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Amgen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Amgen's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Amgen Fundamentals
| Current Valuation | 194.75 B | ||||
| Price To Book | 21.09 X | ||||
| Price To Sales | 5.00 X | ||||
| Revenue | 33.42 B | ||||
| EBITDA | 12.17 B | ||||
| Net Income | 4.09 B | ||||
| Total Debt | 3.55 B | ||||
| Cash Flow From Operations | 11.49 B | ||||
| Price To Earnings To Growth | 1.06 X | ||||
| Market Capitalization | 105.18 B | ||||
| Total Asset | 91.84 B | ||||
| Retained Earnings | (27.59 B) | ||||
| Working Capital | 5.93 B | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 91.84 B |
About Amgen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amgen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amgen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amgen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Amgen Stock Analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.